Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading

Background. Heterogeneity of prostate carcinoma is one of the reasons for pretreatment underestimation of tumor aggressiveness. We studied tumor heterogeneity and the probability of finding the highest tumor grade and DNA aneuploidy with relation to the number of biopsies. Material and methods. Spec...

Full description

Saved in:
Bibliographic Details
Main Authors: Naining Wang, Claudia Wilkin, Alfred Böcking, Bernhard Tribukait
Format: Article
Language:English
Published: Wiley 2000-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2000/489303
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556265724706816
author Naining Wang
Claudia Wilkin
Alfred Böcking
Bernhard Tribukait
author_facet Naining Wang
Claudia Wilkin
Alfred Böcking
Bernhard Tribukait
author_sort Naining Wang
collection DOAJ
description Background. Heterogeneity of prostate carcinoma is one of the reasons for pretreatment underestimation of tumor aggressiveness. We studied tumor heterogeneity and the probability of finding the highest tumor grade and DNA aneuploidy with relation to the number of biopsies. Material and methods. Specimens simulating core biopsies from five randomly selected tumor areas from each of 16 Böcking’s grade II and 23 grade III prostate carcinomas were analyzed for tumor grade and DNA ploidy by flow‐ and fluorescence image cytometry (FCM, FICM). Cell cycle composition was measured by FCM. Results. By determination of ploidy and cell cycle composition, morphologically defined tumors can further be subdivided. Heterogeneity of tumor grade and DNA ploidy (FCM) was 54% and 50%. Coexistence of diploid tumor cells in aneuploid specimens represents another form of tumor heterogeneity. The proportion of diploid tumor cells decreased significantly with tumor grade and with increase in the fraction of proliferating cell of the aneuploid tumor part. The probability of estimating the highest tumor grade or aneuploidy increased from 40% for one biopsy to 95% for 5 biopsies studied. By combining the tumor grade with DNA ploidy, the probability of detecting a highly aggressive tumor increased from 40% to 70% and 90% for one and two biopsies, respectively. Conclusion. Specimens of the size of core biopsies can be used for evaluation of DNA ploidy and cell cycle composition. Underestimation of aggressiveness of prostate carcinoma due to tumor heterogeneity is minimized by simultaneous study of the tumor grade and DNA ploidy more than by increasing the number of biopsies. The biological significance of coexistent diploid tumor cell in aneuploid lesions remains to be evaluated.
format Article
id doaj-art-3549dc6861f549b88cc71089a60f4596
institution Kabale University
issn 0921-8912
1878-3651
language English
publishDate 2000-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-3549dc6861f549b88cc71089a60f45962025-02-03T05:45:54ZengWileyAnalytical Cellular Pathology0921-89121878-36512000-01-01201496210.1155/2000/489303Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological GradingNaining Wang0Claudia Wilkin1Alfred Böcking2Bernhard Tribukait3Department of Medical Radiobiology (N.W., B.T.), Karolinska Institute, Stockholm, SwedenInstitute of Cytopathology (C.W., A.B.), Heinrich Heine University, Dusseldorf, GermanyInstitute of Cytopathology (C.W., A.B.), Heinrich Heine University, Dusseldorf, GermanyDepartment of Medical Radiobiology (N.W., B.T.), Karolinska Institute, Stockholm, SwedenBackground. Heterogeneity of prostate carcinoma is one of the reasons for pretreatment underestimation of tumor aggressiveness. We studied tumor heterogeneity and the probability of finding the highest tumor grade and DNA aneuploidy with relation to the number of biopsies. Material and methods. Specimens simulating core biopsies from five randomly selected tumor areas from each of 16 Böcking’s grade II and 23 grade III prostate carcinomas were analyzed for tumor grade and DNA ploidy by flow‐ and fluorescence image cytometry (FCM, FICM). Cell cycle composition was measured by FCM. Results. By determination of ploidy and cell cycle composition, morphologically defined tumors can further be subdivided. Heterogeneity of tumor grade and DNA ploidy (FCM) was 54% and 50%. Coexistence of diploid tumor cells in aneuploid specimens represents another form of tumor heterogeneity. The proportion of diploid tumor cells decreased significantly with tumor grade and with increase in the fraction of proliferating cell of the aneuploid tumor part. The probability of estimating the highest tumor grade or aneuploidy increased from 40% for one biopsy to 95% for 5 biopsies studied. By combining the tumor grade with DNA ploidy, the probability of detecting a highly aggressive tumor increased from 40% to 70% and 90% for one and two biopsies, respectively. Conclusion. Specimens of the size of core biopsies can be used for evaluation of DNA ploidy and cell cycle composition. Underestimation of aggressiveness of prostate carcinoma due to tumor heterogeneity is minimized by simultaneous study of the tumor grade and DNA ploidy more than by increasing the number of biopsies. The biological significance of coexistent diploid tumor cell in aneuploid lesions remains to be evaluated.http://dx.doi.org/10.1155/2000/489303
spellingShingle Naining Wang
Claudia Wilkin
Alfred Böcking
Bernhard Tribukait
Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
Analytical Cellular Pathology
title Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
title_full Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
title_fullStr Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
title_full_unstemmed Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
title_short Evaluation of Tumor Heterogeneity of Prostate Carcinoma by Flow- and Image DNA Cytometry and Histopathological Grading
title_sort evaluation of tumor heterogeneity of prostate carcinoma by flow and image dna cytometry and histopathological grading
url http://dx.doi.org/10.1155/2000/489303
work_keys_str_mv AT nainingwang evaluationoftumorheterogeneityofprostatecarcinomabyflowandimagednacytometryandhistopathologicalgrading
AT claudiawilkin evaluationoftumorheterogeneityofprostatecarcinomabyflowandimagednacytometryandhistopathologicalgrading
AT alfredbocking evaluationoftumorheterogeneityofprostatecarcinomabyflowandimagednacytometryandhistopathologicalgrading
AT bernhardtribukait evaluationoftumorheterogeneityofprostatecarcinomabyflowandimagednacytometryandhistopathologicalgrading